Nonalcoholic fatty liver disease and its association with cardiovascular disease

array:24 ["pii" => "S1665268119318253" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)31825-3" "estado" => "S300" "fechaPublicacion" => "2009-01-01" "aid" => "71487" "copyright" => "Fundación Clínica Médica Sur, A.C." "copyrightAnyo" => "2009" "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2009;8 Supl 1:S40-3" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 72 "formatos" => array:3 [ "EPUB" => 7 "HTML" => 30 "PDF" => 35 ] ] "itemSiguiente" => array:19 [ "pii" => "S1665268119318265" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)31826-5" "estado" => "S300" "fechaPublicacion" => "2009-01-01" "aid" => "71488" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2009;8 Supl 1:S44-50" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 66 "formatos" => array:3 [ "EPUB" => 10 "HTML" => 25 "PDF" => 31 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Association between type two diabetes and non-alcoholic fatty liver disease in youth" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S44" "paginaFinal" => "S50" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Anna Alisi, Melania Manco, Nadia Panera, Valerio Nobili" "autores" => array:4 [ 0 => array:2 [ "nombre" => "Anna" "apellidos" => "Alisi" ] 1 => array:2 [ "nombre" => "Melania" "apellidos" => "Manco" ] 2 => array:2 [ "nombre" => "Nadia" "apellidos" => "Panera" ] 3 => array:2 [ "nombre" => "Valerio" "apellidos" => "Nobili" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119318265?idApp=UINPBA00004N" "url" => "/16652681/00000008000000S1/v1_201906260858/S1665268119318265/v1_201906260858/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1665268119318241" "issn" => "16652681" "doi" => "10.1016/S1665-2681(19)31824-1" "estado" => "S300" "fechaPublicacion" => "2009-01-01" "aid" => "71486" "copyright" => "Fundación Clínica Médica Sur, A.C." "documento" => "article" "crossmark" => 0 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "fla" "cita" => "Ann Hepatol. 2009;8 Supl 1:S34-9" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 54 "formatos" => array:3 [ "EPUB" => 8 "HTML" => 21 "PDF" => 25 ] ] "en" => array:10 [ "idiomaDefecto" => true "titulo" => "Role of nonalcoholic fatty liver disease in hepatocellular carcinoma" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S34" "paginaFinal" => "S39" ] ] "contieneResumen" => array:1 [ "en" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Norberto C. Chávez-Tapia, Nahum Méndez-Sánchez, Misael Uribe" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Norberto C." "apellidos" => "Chávez-Tapia" ] 1 => array:2 [ "nombre" => "Nahum" "apellidos" => "Méndez-Sánchez" ] 2 => array:2 [ "nombre" => "Misael" "apellidos" => "Uribe" ] ] ] ] ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119318241?idApp=UINPBA00004N" "url" => "/16652681/00000008000000S1/v1_201906260858/S1665268119318241/v1_201906260858/en/main.assets" ] "en" => array:17 [ "idiomaDefecto" => true "titulo" => "Nonalcoholic fatty liver disease and its association with cardiovascular disease" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "S40" "paginaFinal" => "S43" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Javier Lizardi-Cervera, Daniel Aguilar-Zapata" "autores" => array:2 [ 0 => array:4 [ "nombre" => "Javier" "apellidos" => "Lizardi-Cervera" "email" => array:1 [ 0 => "jlizardi@medicasur.org.mx" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "1" "identificador" => "aff1" ] 1 => array:2 [ "etiqueta" => "*" "identificador" => "cor1" ] ] ] 1 => array:3 [ "nombre" => "Daniel" "apellidos" => "Aguilar-Zapata" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "2" "identificador" => "aff2" ] ] ] ] "afiliaciones" => array:2 [ 0 => array:3 [ "entidad" => "Department of Gastroenterology and Internal Medicine" "etiqueta" => "1" "identificador" => "aff1" ] 1 => array:3 [ "entidad" => "Medica Sur Clinic & Foundation. Mexico City. Mexico" "etiqueta" => "2" "identificador" => "aff2" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor1" "etiqueta" => "*" "correspondencia" => "Address for correspondence:" ] ] ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "f0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 680 "Ancho" => 977 "Tamanyo" => 41026 ] ] "descripcion" => array:1 [ "en" => "The prevalence of CVD in patients with NAFLD associated to type 2 diabetes mellitus." ] ] ] "textoCompleto" => "Non-Alcoholic Fatty Liver Disease (NAFLD) constitutes one of the most common forms of liver disease and is considered as the hepatic manifestation of the Metabolic Syndrome (MS)<a class="elsevierStyleCrossRef" href="#bib0005">1</a> since it is also strongly associated to obesity and insulin resistance.The severity of NAFLD ranges from hepatic steatosis alone to a triad constituted by: steatosis, hepatocellular necrosis, and inflammation; referred to as non alcoholic steatohepatitis (NASH).<a class="elsevierStyleCrossRef" href="#bib0010">2</a>The true prevalence of NAFLD remains unknown. Among the difficulties in assesing NAFLD prevalence are the absence of signs and symptoms, the sensitivity of liver enzimes to indicate disease and the disputed need for histopatology (liver biopsy) as a gold standard for diagnosis. Depending on which specific diagnosis criteria are used, the prevalence of NAFLD is estimated to range between 10% and 24% in the general population. Variability arises from country to country; in Mexico, one of the largest NAFLD studies<a class="elsevierStyleCrossRef" href="#bib0015">3</a> reported a frequency of 14.34% in the population between ages 15 and 80 years, compared to a prevalence of 10 to 24% reported in the United States.<a class="elsevierStyleCrossRef" href="#bib0020">4</a>In cirrhotic patients<a class="elsevierStyleCrossRef" href="#bib0025">5</a> liver-related causes of death are classically the main concern in clinical practice; most research is being developed in this field. The most important risk factors for the development of Cardiovascular Disease (CVD) in cirrhotic patients have been analyzed (except for those with primary biliary cirrhosis and nonalcoholic steatohepatitis), considering CVD is a new but less studied risk that will be increasingly common in this population due to the improved survival that has been observed worldwide. The first interesting finding was that the overall prevalence of MS in patients with liver cirrhosis was similar to that in patients without cirrhosis; although a lower prevalence was observed in male cir-rhotic patients. It is clear that MS is a significant clinical problem in this population, mainly because there are currently no specific guidelines for treatment of MS in patients with liver damage, and controlled clinical trials to prevent complications of MS do not include participants with liver cirrhosis.Insulin resistance is the underlying condition that facilitates NAFLD’s occurrence and is the key patho-genetic event of obesity, type 2 Diabetes Mellitus and dyslipidemia. Recently, NAFLD has been included among components of the metabolic syndrome; condition that increases the risk of coronary heart disease and cardiovascular complications. A high prevalence of fatty liver, evaluated by ultrasound, associated with hyperinsulinemia or insulin resistance and cardiovascular disease, has been reported in the general population and in patients with documented coronary artery disease or stroke.Carotid B mode ultrasound imaging has been used to evaluate carotid atherosclerosis. Intima-media thickness of the carotid artery, a valid parameter for detecting sub-clinical atherosclerosis, has been shown to predict myo-cardial infarction and stroke. Recently, a relationship between NAFLD and atherosclerosis has been reported in healthy man and it has been suggested to reflect the overall adverse impact of the metabolic syndrome, in particular of insulin resistance and increased visceral fat. Endot-helial dysfunction has been reported in NAFLD and re-lated to the metabolic syndrome.The main problemThe current importance of NAFLD and its relationship with the MS has stimulated an interest in the possible role of NAFLD in the development of atherosclerosis. Recent studies have reported the association of NAFLD with multiple classical and non-classical risk factors for CVD. Moreover, there is a strong association between the severity of liver histopathology in NAFLD patients and greater carotid artery intima-media thickness and plaque, and lower endothelial flow-mediated vasodilation (as markers of subclinical atherosclerosis) independently of obesity and other MS components.<a class="elsevierStyleCrossRef" href="#bib0030">6</a>,<a class="elsevierStyleCrossRef" href="#bib0035">7</a><a class="elsevierStyleCrossRef" href="#t0005">Table I</a> shows studies regarding to CVD and the presence of NAFLD and NASH.<elsevierMultimedia ident="t0005"></elsevierMultimedia>The Free Fatty Acids (FFAs) are increased in obese patients and contribute to the development of type 2 Diabetes Mellitus, hepatic steatosis and several cardiovascular diseases. In patients with heart failure and acute coronary syndromes, elevated FFA levels are a consequence of an increased lipolysis due to a surge in catecholamines and natriuretic peptides. FFAs contribute to myocardial dysfunction and are proarrhythmic; also, their oxidation process requires more oxygen than glycolysis.<a class="elsevierStyleCrossRef" href="#bib0040">8</a> More recently, several cross-sectional and prospective studies have demonstrated associations of this mechanism with features of the metabolic syndrome and type 2 diabetes mellitus.<a class="elsevierStyleCrossRef" href="#bib0045">9</a>Several epidemiological studies indicate that NAFLD, especially in its more severe forms, is linked to an increased risk of CVD, independently of underlying cardi-ometabolic risk factors; Targher et al <a class="elsevierStyleCrossRef" href="#bib0050">10</a> found that NAFLD is not merely a marker of CVD, but it may be actively involved in its pathogenesis.In the Diabetes Care work study from Targher,<a class="elsevierStyleCrossRef" href="#bib0055">11</a> it was found that the prevalence of NAFLD increased with age in patients with type 2 diabetes; (65.4% in aged 40-59 years and 74.6% among those > 60 years; P < 0.001) and the age-adjusted prevalence of NAFLD was 71.1% in men and 68% in women. NAFLD patients had remarkably (P < 0.001) higher age and sex-adjusted prevalences of coronary (26.6% vs 18.3%), cerebrovascular (20.0% vs 13.3%), and peripheral (15.4% vs 10.0%) vascular disease than their counterparts without NAFLD <a class="elsevierStyleCrossRef" href="#f0005">(Figure 1).</a><elsevierMultimedia ident="f0005"></elsevierMultimedia>Abdeen et al state that in the cardiometabolic syndrome (a constellation of metabolic, cardiovascular, renal, and inflammatory abnormalities in which insulin resistance is thought to play a key role in end-organ patho-genesis),<a class="elsevierStyleCrossRef" href="#bib0060">12</a> the release of pro-atherogenic factors from the liver (C-reactive protein, fibrinogen, plasminogen activator inhibitor-1 and other inflammatory cytokines) as well as the contribution of NAFLD per se to whole-body insulin resistance and atherogenic dyslipidemia, favour CVD progression.Plasma concentrations of high-sensitivity C-reactive protein (hs-CRP), fibrinogen, plasminogen activator in-hibitor-1 (PAI-1) activity, and adiponectin were reviewed by Targher et al in 45 overweight male patients with biopsy-proven NASH, 45 overweight male patients without ultrasound-diagnosed hepatic steatosis, and 45 healthy male volunteers;<a class="elsevierStyleCrossRef" href="#bib0065">13</a> the lowest values were in nonobese healthy subjects, intermediate in overweight nonsteatotic patients, and the highest in those with biopsy-proven NASH; on the other hand, the highest and lowest adi-ponectin levels were found in nonobese healty subjects and in biopsy-proven NASH patients, respectively. In their review, they concluded that the presence of NASH can predict a more atherogenic risk profile in a manner that is partly independent from the contribution of visceral adiposity in adult men.A large trial performed in Asia with 30,172 subjects studied the severity of NAFLD, characterized a nonobese population and analyzed the prevalence of CVD risk factors and used the Framingham risk score for CVD; the odds ratio for 10-year risk by total Framingham risk scores > 10% was 5.3 times higher in NASH groups. CVD risk was significantly greater in patients with NASH than in patients with either steatosis or raised ALT alone.<a class="elsevierStyleCrossRef" href="#bib0070">14</a>Lizardi-Cervera et al<a class="elsevierStyleCrossRef" href="#bib0075">15</a> demonstrated that subjects with NAFLD had several forms of metabolic disturbances and a high prevalence of MS. They found higher levels of uCRP (ultrasensitivity C-reactive protein) in subjects with NAFLD and observed in this subjects had more metabolic abnormalities and a higher prevalence of MS; which explained the higher concentrations of uCRP. They compared 310 subjects with ultrasound-demonstrated steatosis to 610 control cases. They found statistically significant differences between both groups; the frequency of MS was 66.4% in the study population compared to 26.7% found in the control group (P < 0.001). Patients in the steatosis group were older, had higher BMIs, glucose, total cholesterol and triglycerides (P < 0.001), as well as mean uCRP concentrations (4.5 vs 2.79 mg/L; P < 0.001) <a class="elsevierStyleCrossRef" href="#t0010">(Table II).</a> Cardiovascular risk was also higher in subjects with NAFLD (4.7 vs 2.8) <a class="elsevierStyleCrossRef" href="#f0010">(Figure 2).</a><elsevierMultimedia ident="t0010"></elsevierMultimedia><elsevierMultimedia ident="f0010"></elsevierMultimedia>With regard to carotid atherosclerosis, a significant difference in mean values of intima-media thickness (0.89 + 0.26 vs 0.64 + 0.14 mm, P = .0001) and prevalence of plaques (26 [21%] vs 15 [6%], P < .001) was observed between nonalcoholic fatty liver disease patients and controls in a study performed by Francanzani et al<a class="elsevierStyleCrossRef" href="#bib0080">16</a> in 375 patients (125 patients with NAFLD and 250 controls).Steatosis was the strongest variable independently associated to intima-media thickness and to an increased risk of atherosclerosis in subjects with metabolic syndrome. It is important to mention that the strongest independent risk predictor of vascular damage was steatosis followed by age and systolic blood pressure.It was recently shown that patients with NAFLD have endothelial dysfunction potentially responsible for cardiovascular disease in the long term<a class="elsevierStyleCrossRef" href="#bib0085">17</a>. Enhaced oxidative stress, inflammation with release of inflammatory cytokines, and abnormal lipoprotein metabolism could account for the proatherogenic effect of NAFLD; in addition to this, increased levels of ox-LDL in patients with higher intima media thickness. Visceral fat, even in normal weight or slightly overweight subjects with steatosis, could play a direct role in the development of atherosclerosis through multiple secreted factors.<a class="elsevierStyleCrossRef" href="#bib0090">18</a>Also, a Turkish study by Cikim<a class="elsevierStyleCrossRef" href="#bib0095">19</a> evaluated the relationship between hepatic steatosis, epicardial adipose tissue (EAT) and insulin resistance in obese patients. They found EAT was high in all groups, suggesting that hepatic steatosis should be assessed as a predictor that reflects the increments of whole body fat mass as well as abdominal adiposity.The Study of Chavez-Tapia et al in Mexico City an-alized 1,421 subjects with NAFLD and MS. Among these patients a systolic blood pressure > 130 mmHg was associated with a positive treadmill test with an OR = 4.705 (95% CI 1.285-17.231). Interestingly, waist circumference an MS remained as risk factors related to positive treadmill tests (OR = 8.750, 95%CI 1.83041.843; and OR = 3.802, 95% CI 1.121-12.987, respec-tivetely). They concluded that subjects with NAFLD and high systolic blood preassure are at increased risk to develop CVD.<a class="elsevierStyleCrossRef" href="#bib0100">20</a>ConclusionsToday’s lifestyle represents a huge challenge for health-care providers. Most meals are full of carbs, lipids and have high caloric contents; thus helping to increase the prevalence of MS and its consequences such as NAFLD and increased CVD-related mortality.As mentioned above, NAFLD is associated to an increased risk to develop cardiovascular disease which augments as the hepatic damage progresses. The presence of NAFLD would predict a higher atherogenic risk regardless of the other components of the MS. It is proba-ble that NAFLD may not be a marker of CVD, but it may certainly be involved in its pathogenesis; more studies are needed to prove this hypothesis. Patients with NAFLD regardless of their liver function tests should be considered at a higher risk to develop complications from CVD.What we see today is yet the top of the iceberg of what could be one of the main diseases for the years to come since the incidence of both MS and NAFLD will increase. It is of serious importance to take an aggressive preventive measures in this group of patients." "textoCompletoSecciones" => array:1 [ "secciones" => array:5 [ 0 => array:3 [ "identificador" => "xres1212005" "titulo" => "Abstract" "secciones" => array:1 [ 0 => array:1 [ "identificador" => "abst0005" ] ] ] 1 => array:2 [ "identificador" => "xpalclavsec1128075" "titulo" => "Key words" ] 2 => array:2 [ "identificador" => "sec0005" "titulo" => "The main problem" ] 3 => array:2 [ "identificador" => "sec0010" "titulo" => "Conclusions" ] 4 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "fechaRecibido" => "2008-10-17" "fechaAceptado" => "2008-10-17" "PalabrasClave" => array:1 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Key words" "identificador" => "xpalclavsec1128075" "palabras" => array:2 [ 0 => "NAFLD" 1 => "NASH and cardiovascular disease" ] ] ] ] "tieneResumen" => true "resumen" => array:1 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "An association between non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) has been recently suggested. Indeed, different studies have demonstrated that NAFLD patients present increased subclinical atherosclerosis compared to non-steatosic individuals, and are supported by the few follow-up studies revealing that CVD is the second most common cause of death in NAFLD patients. However, the nature of the relationship NAFLD/CVD is still under debate." ] ] "multimedia" => array:4 [ 0 => array:7 [ "identificador" => "f0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 680 "Ancho" => 977 "Tamanyo" => 41026 ] ] "descripcion" => array:1 [ "en" => "The prevalence of CVD in patients with NAFLD associated to type 2 diabetes mellitus." ] ] 1 => array:7 [ "identificador" => "f0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 906 "Ancho" => 980 "Tamanyo" => 41063 ] ] "descripcion" => array:1 [ "en" => "Relative risk for cardiovascular disease between cases and patients with NAFLD." ] ] 2 => array:7 [ "identificador" => "t0005" "etiqueta" => "Table I" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Author \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Year \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Population \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">N \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Findings \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Sankatsing \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2005 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Dyslipidemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">32 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Familiar dyslipidema is a risk factor for NAFLD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Santoliquido \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2005 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">1209 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2,1 Relative risk to develop stroke in patients with NAFLD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Abden \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2006 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD and NASH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Review \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD and NASK is a risk factor for CVD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Browning \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2006 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD and NASH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2264 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Statin use is not associated to an increased NAFLD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Targher \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2006 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD and NASH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">85 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD is associated to increased incidence of carotid atherosclerosis and hepatic damage \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Schindhelm \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2007 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Review \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Association of ALT level with the development of CVD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Targher \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2007 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Review \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">The association between severity of hepatic damage and the intima-media thickness of the carotid artery \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Cikim \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2007 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">63 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD and its association to increased epidardic adipose tissue, insulin resistance and high levels of C-Reactive protein \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Lizardi-Cervera \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2007 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">310 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">higher levels of uCRP (ultrasensitivity C-reactive protein) in subjects with NAFLD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Akabame \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2008 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">298 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2.6 Relative Risk of having coronary atherosclerosis in patients with NAFLD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Francanzani \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2008 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">375 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD and its association of the intima thinnering of the carotid artery and hypertension \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Sung KC \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2008 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD and NASH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">30, 172 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">5.3 Relative Risk of CVD in NASH than in other NAFLD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Targher \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2008 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD and TYPE 2 DM \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">52 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NAFLD as a independent risk factor of CVD and atherosclerosis \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Targher \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2008 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NASH \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">45 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">High levels of C-Reactive protein, fibrinogen, plasminogen and cytokines \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Targher \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2008 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">NASH and obesity \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">45 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Non-obese patients with NASH have increased risk to develop CVD \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Pilz \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2008 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Obesity, NAFLD and CVD \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Review \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">Increased incidence of Free Fatty Acids in blood serum \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2069123.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Studies regarding to CVD and the presence of NAFLD and NASH." ] ] 3 => array:7 [ "identificador" => "t0010" "etiqueta" => "Table II." "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:1 [ "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="middle" scope="col">Variable \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="center" valign="middle" scope="col">OR (CI95%) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="center" valign="middle" scope="col">p value \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Age: >45 vs <45 years \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">1.90 (1.44-2.51) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">< 0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Gender: male vs female \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">1.78 (1.40-2.26) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">< 0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">BMI: > 27 vs < 27 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">5.54 (4.09-7.49) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">< 0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Glucose: > 5.55 vs < 5.55 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">mmol/L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">4.09 (2.98-5.61) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">< 0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Total cholesterol: > 2.59 vs > \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">2.59 mmol/L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">1.71 (1.29-2.27) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">< 0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">HDL cholesterol: < 1.16 vs > \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">1.16 mmol/L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">2.15 (1.58-2.91) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">< 0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">Triglycerides: > 2.26 vs < \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle"> \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle"> \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">2.26 mmol/L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">3.34 (2.50-4.46) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">< 0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">CPR > 3 vs < 1 mg/L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">7.06 (4.51-11.02) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">< 0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="middle">CPR > 3 vs < 1 mg/L \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">5.83 (3.07-11.06) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="center" valign="middle">< 0.001 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab2069122.png" ] ] ] ] "descripcion" => array:1 [ "en" => "Univariated and multivariated analysis of anthropometric and metabolic variables and C reactive protein values according to cardiovascular risk." ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:20 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Obesidad y esteatohepatitis no alcohólica" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N Méndez-Sánchez" 1 => "N Chávez-Tapia" 2 => "M. Unbe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Gac Med Méx" "fecha" => "2004" "numero" => "140" "paginaInicial" => "S67" "paginaFinal" => "S72" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Relación entre el sobrepeso y obesidad con mortalidad por cirrosis hepática en México" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N Méndez-Sánchez" 1 => "C.P. Sánchez-Castillo" 2 => "A.R. Villar" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "Rev Gastroenterol Mex" "fecha" => "2003" "volumen" => "68" "numero" => "Supl 3" "paginaInicial" => "176" ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Hígado graso no alcohólico y síndrome metabólico" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J Lizardi-Cervera" 1 => "I Becerra-Laparra" 2 => "N Chávez-Tapia" 3 => "Me. RamosOstos" 4 => "M. Uribe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "Rev Gastroenterol Mex" "fecha" => "2006" "volumen" => "71" "numero" => "4" "paginaInicial" => "453" "paginaFinal" => "459" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17542278" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nonalcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "P. Angulo" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1056/NEJMra011775" "Revista" => array:7 [ "tituloSerie" => "N Engl J Med" "fecha" => "2002" "volumen" => "346" "numero" => "16" "paginaInicial" => "1221" "paginaFinal" => "1231" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11961152" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Metabolic syndrome and estimates of cardiovascular disease in cirrhotic patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:7 [ 0 => "N Chávez-Tapia" 1 => "F Téllez-Ávila" 2 => "M Valdés-Escárcega" 3 => "M Montaño-Reyes" 4 => "M.H. Ramos" 5 => "J Lizardi-Cervera" 6 => "M. Uribe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "J Dig Dis" "fecha" => "2008" "volumen" => "9" "paginaInicial" => "149" "paginaFinal" => "155" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18956593" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Increased risk of cardiovascular disease in non-alcoholic fatty liver disease: causal effect or epiphenomenon?" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G Targher" 1 => "F Marra" 2 => "G. Marchesini" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00125-008-1135-4" "Revista" => array:8 [ "tituloSerie" => "Diabetologia" "fecha" => "2008" "volumen" => "51" "numero" => "11" "paginaInicial" => "1947" "paginaFinal" => "1953" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18762907" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S0161642017324533" "estado" => "S300" "issn" => "01616420" ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Obesity, inflammation, and insulin resistance" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "S.E. Shoelson" 1 => "L Herrero" 2 => "A. Naaz" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1053/j.gastro.2007.03.059" "Revista" => array:6 [ "tituloSerie" => "Gastroenterology" "fecha" => "2007" "volumen" => "132" "paginaInicial" => "2169" "paginaFinal" => "2180." "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17498510" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Free fatty acids as a cardiovascular risk factor" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "S Pilz" 1 => "W. März" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1515/CCLM.2008.118" "Revista" => array:7 [ "tituloSerie" => "Clin Chem Lab Med" "fecha" => "2008" "volumen" => "46" "numero" => "4" "paginaInicial" => "429" "paginaFinal" => "434" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18605928" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Obesity increases sensitivity to exotoxin liver injury: Implications for the pathogenesis of steatohepatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S.Q. Yang" 1 => "H.Z. Lin" 2 => "M.D. Lande" 3 => "M Clemens" 4 => "AM. Diehl" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1073/pnas.94.6.2557" "Revista" => array:7 [ "tituloSerie" => "Proc Natl Acad Sci USA" "fecha" => "1997" "volumen" => "94" "numero" => "6" "paginaInicial" => "2557" "paginaFinal" => "2562" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9122234" "web" => "Medline" ] ] ] ] ] ] ] ] 9 => array:3 [ "identificador" => "bib0050" "etiqueta" => "10." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "G. Targher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1464-5491.2007.02125.x" "Revista" => array:7 [ "tituloSerie" => "Diabet Med" "fecha" => "2007" "volumen" => "24" "numero" => "1" "paginaInicial" => "1" "paginaFinal" => "6" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17313594" "web" => "Medline" ] ] ] ] ] ] ] ] 10 => array:3 [ "identificador" => "bib0055" "etiqueta" => "11." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:8 [ 0 => "G Targher" 1 => "L Bertolini" 2 => "R Padovani" 3 => "S Rodella" 4 => "R Tessari" 5 => "L Zenari" 6 => "C Day" 7 => "G. Arcaro" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.2337/dc06-2247" "Revista" => array:7 [ "tituloSerie" => "Diabetes Care" "fecha" => "2007" "volumen" => "30" "numero" => "5" "paginaInicial" => "1212" "paginaFinal" => "1218" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17277038" "web" => "Medline" ] ] ] ] ] ] ] ] 11 => array:3 [ "identificador" => "bib0060" "etiqueta" => "12." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Nonalcoholic steatohepatitis and the cardiometabolic syndrome" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "M.B. Abdeen" 1 => "N.A. Chowdhury" 2 => "M.R. Hayden" 3 => "JA. Ibdah" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:7 [ "tituloSerie" => "J Cardiometab Syndr" "fecha" => "2006" "volumen" => "1" "numero" => "1" "paginaInicial" => "36" "paginaFinal" => "40" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17675901" "web" => "Medline" ] ] ] ] ] ] ] ] 12 => array:3 [ "identificador" => "bib0065" "etiqueta" => "13." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "NASH predicts plasma inflammatory biomarkers independently of visceral fat in men" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:8 [ 0 => "G Targher" 1 => "L Bertolini" 2 => "S Rodella" 3 => "G Lippi" 4 => "M Franchini" 5 => "G Zoppini" 6 => "M Muggeo" 7 => "CP. Day" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1038/oby.2008.64" "Revista" => array:7 [ "tituloSerie" => "Obesity" "fecha" => "2008" "volumen" => "16" "numero" => "6" "paginaInicial" => "1394" "paginaFinal" => "1399" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18369343" "web" => "Medline" ] ] ] ] ] ] ] ] 13 => array:3 [ "identificador" => "bib0070" "etiqueta" => "14." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "K.C. Sung" 1 => "M.C. Ryan" 2 => "A.M. Wilson" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:3 [ "tituloSerie" => "Atherosclerosis" "fecha" => "2008" "itemHostRev" => array:3 [ "pii" => "S0161642017324533" "estado" => "S300" "issn" => "01616420" ] ] ] ] ] ] ] 14 => array:3 [ "identificador" => "bib0075" "etiqueta" => "15." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Association among C-reactive protein, Fatty liver disease, and cardiovascular risk" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "J Lizardi-Cervera" 1 => "N.C. Chávez-Tapia" 2 => "O Pérez-Bautista" 3 => "M.H. Ramos" 4 => "M. Uribe" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s10620-006-9262-6" "Revista" => array:7 [ "tituloSerie" => "Dig Dis Sci" "fecha" => "2007" "volumen" => "52" "numero" => "9" "paginaInicial" => "2375" "paginaFinal" => "2379" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17458697" "web" => "Medline" ] ] ] ] ] ] ] ] 15 => array:3 [ "identificador" => "bib0080" "etiqueta" => "16." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Carotid artery intima-media thickness in nonalcoholic fatty liver disease." "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:10 [ 0 => "A.L. Fracanzani" 1 => "L Burdick" 2 => "S Raselli" 3 => "P Pedotti" 4 => "L Grigore" 5 => "G Santorelli" 6 => "L Valenti" 7 => "A Maraschi" 8 => "A Catapano" 9 => "S. Fargion" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.amjmed.2007.08.041" "Revista" => array:7 [ "tituloSerie" => "Am J Med" "fecha" => "2008" "volumen" => "121" "numero" => "1" "paginaInicial" => "72" "paginaFinal" => "78" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18187076" "web" => "Medline" ] ] ] ] ] ] ] ] 16 => array:3 [ "identificador" => "bib0085" "etiqueta" => "17." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N Villanova" 1 => "S Moscatiello" 2 => "S. Ramillis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1002/hep.20781" "Revista" => array:6 [ "tituloSerie" => "Hepatology" "fecha" => "2005" "volumen" => "42" "paginaInicial" => "473" "paginaFinal" => "480." "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15981216" "web" => "Medline" ] ] ] ] ] ] ] ] 17 => array:3 [ "identificador" => "bib0090" "etiqueta" => "18." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "N Chalasani" 1 => "M.A. Deeg" 2 => "DW. Crab" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1572-0241.2004.30159.x" "Revista" => array:6 [ "tituloSerie" => "Am J Gastroenterol" "fecha" => "2004" "volumen" => "99" "paginaInicial" => "1497" "paginaFinal" => "1502" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15307867" "web" => "Medline" ] ] ] ] ] ] ] ] 18 => array:3 [ "identificador" => "bib0095" "etiqueta" => "19." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Epicardial adipose tissue, hepatic steatosis and obesity" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:9 [ 0 => "A.S. Cikim" 1 => "E Topal" 2 => "M Harputluoglu" 3 => "L Keskin" 4 => "Z Zengin" 5 => "K Cikim" 6 => "R Ozdemir" 7 => "M Aladag" 8 => "S. Yologlu" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/BF03346328" "Revista" => array:7 [ "tituloSerie" => "J Endocrinol Invest" "fecha" => "2007" "volumen" => "30" "numero" => "6" "paginaInicial" => "459" "paginaFinal" => "464" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17646719" "web" => "Medline" ] ] ] ] ] ] ] ] 19 => array:3 [ "identificador" => "bib0100" "etiqueta" => "20." "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Differential risk factor patterns for a positive treadmill test among subjects with and without ultrasound-based fatty liver" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:9 [ 0 => "N Chavez-Tapia" 1 => "F.I. Tellez-Avila" 2 => "M Valdes-Escarcega" 3 => "O Perez-Bautista" 4 => "J Lizardi-Cervera" 5 => "N Méndez-Sánchez" 6 => "J.F. Sánchez-Avila" 7 => "M.H. Ramos" 8 => "M. Uribe" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:2 [ "tituloSerie" => "Arch Med Sci" "fecha" => "2009" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/16652681/00000008000000S1/v1_201906260858/S1665268119318253/v1_201906260858/en/main.assets" "Apartado" => null "PDF" => "https://static.elsevier.es/multimedia/16652681/00000008000000S1/v1_201906260858/S1665268119318253/v1_201906260858/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119318253?idApp=UINPBA00004N"]

Statistics

Javier Lizardi-Cervera1,

Corresponding author

jlizardi@medicasur.org.mx

Address for correspondence:

, Daniel Aguilar-Zapata2

1 Department of Gastroenterology and Internal Medicine

2 Medica Sur Clinic & Foundation. Mexico City. Mexico

Read

2164

Times
was read the article

519

Total PDF

1645

Total HTML

Share statistics

 array:24 [
  "pii" => "S1665268119318253"
  "issn" => "16652681"
  "doi" => "10.1016/S1665-2681(19)31825-3"
  "estado" => "S300"
  "fechaPublicacion" => "2009-01-01"
  "aid" => "71487"
  "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
  "copyrightAnyo" => "2009"
  "documento" => "article"
  "crossmark" => 0
  "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
  "subdocumento" => "fla"
  "cita" => "Ann Hepatol. 2009;8 Supl 1:S40-3"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 72
    "formatos" => array:3 [
      "EPUB" => 7
      "HTML" => 30
      "PDF" => 35
    ]
  ]
  "itemSiguiente" => array:19 [
    "pii" => "S1665268119318265"
    "issn" => "16652681"
    "doi" => "10.1016/S1665-2681(19)31826-5"
    "estado" => "S300"
    "fechaPublicacion" => "2009-01-01"
    "aid" => "71488"
    "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Ann Hepatol. 2009;8 Supl 1:S44-50"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 66
      "formatos" => array:3 [
        "EPUB" => 10
        "HTML" => 25
        "PDF" => 31
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Association between type two diabetes and non-alcoholic fatty liver disease in youth"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "S44"
          "paginaFinal" => "S50"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Anna Alisi, Melania Manco, Nadia Panera, Valerio Nobili"
          "autores" => array:4 [
            0 => array:2 [
              "nombre" => "Anna"
              "apellidos" => "Alisi"
            ]
            1 => array:2 [
              "nombre" => "Melania"
              "apellidos" => "Manco"
            ]
            2 => array:2 [
              "nombre" => "Nadia"
              "apellidos" => "Panera"
            ]
            3 => array:2 [
              "nombre" => "Valerio"
              "apellidos" => "Nobili"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119318265?idApp=UINPBA00004N"
    "url" => "/16652681/00000008000000S1/v1_201906260858/S1665268119318265/v1_201906260858/en/main.assets"
  ]
  "itemAnterior" => array:19 [
    "pii" => "S1665268119318241"
    "issn" => "16652681"
    "doi" => "10.1016/S1665-2681(19)31824-1"
    "estado" => "S300"
    "fechaPublicacion" => "2009-01-01"
    "aid" => "71486"
    "copyright" => "Fundaci&#243;n Cl&#237;nica M&#233;dica Sur&#44; A&#46;C&#46;"
    "documento" => "article"
    "crossmark" => 0
    "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/"
    "subdocumento" => "fla"
    "cita" => "Ann Hepatol. 2009;8 Supl 1:S34-9"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 54
      "formatos" => array:3 [
        "EPUB" => 8
        "HTML" => 21
        "PDF" => 25
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "Role of nonalcoholic fatty liver disease in hepatocellular carcinoma"
      "tienePdf" => "en"
      "tieneTextoCompleto" => "en"
      "tieneResumen" => "en"
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "S34"
          "paginaFinal" => "S39"
        ]
      ]
      "contieneResumen" => array:1 [
        "en" => true
      ]
      "contieneTextoCompleto" => array:1 [
        "en" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "Norberto C&#46; Ch&#225;vez-Tapia, Nahum M&#233;ndez-S&#225;nchez, Misael Uribe"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "Norberto C&#46;"
              "apellidos" => "Ch&#225;vez-Tapia"
            ]
            1 => array:2 [
              "nombre" => "Nahum"
              "apellidos" => "M&#233;ndez-S&#225;nchez"
            ]
            2 => array:2 [
              "nombre" => "Misael"
              "apellidos" => "Uribe"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119318241?idApp=UINPBA00004N"
    "url" => "/16652681/00000008000000S1/v1_201906260858/S1665268119318241/v1_201906260858/en/main.assets"
  ]
  "en" => array:17 [
    "idiomaDefecto" => true
    "titulo" => "Nonalcoholic fatty liver disease and its association with cardiovascular disease"
    "tieneTextoCompleto" => true
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "S40"
        "paginaFinal" => "S43"
      ]
    ]
    "autores" => array:1 [
      0 => array:4 [
        "autoresLista" => "Javier Lizardi-Cervera, Daniel Aguilar-Zapata"
        "autores" => array:2 [
          0 => array:4 [
            "nombre" => "Javier"
            "apellidos" => "Lizardi-Cervera"
            "email" => array:1 [
              0 => "jlizardi@medicasur.org.mx"
            ]
            "referencia" => array:2 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">1</span>"
                "identificador" => "aff1"
              ]
              1 => array:2 [
                "etiqueta" => "&#42;"
                "identificador" => "cor1"
              ]
            ]
          ]
          1 => array:3 [
            "nombre" => "Daniel"
            "apellidos" => "Aguilar-Zapata"
            "referencia" => array:1 [
              0 => array:2 [
                "etiqueta" => "<span class="elsevierStyleSup">2</span>"
                "identificador" => "aff2"
              ]
            ]
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:3 [
            "entidad" => "Department of Gastroenterology and Internal Medicine"
            "etiqueta" => "1"
            "identificador" => "aff1"
          ]
          1 => array:3 [
            "entidad" => "Medica Sur Clinic &#38; Foundation&#46; Mexico City&#46; Mexico"
            "etiqueta" => "2"
            "identificador" => "aff2"
          ]
        ]
        "correspondencia" => array:1 [
          0 => array:3 [
            "identificador" => "cor1"
            "etiqueta" => "&#42;"
            "correspondencia" => "Address for correspondence&#58;"
          ]
        ]
      ]
    ]
    "resumenGrafico" => array:2 [
      "original" => 0
      "multimedia" => array:7 [
        "identificador" => "f0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 680
            "Ancho" => 977
            "Tamanyo" => 41026
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="sp0005" class="elsevierStyleSimplePara elsevierViewall">The prevalence of CVD in patients with NAFLD associated to type 2 diabetes mellitus&#46;</p>"
        ]
      ]
    ]
    "textoCompleto" => "<span class="elsevierStyleSections"><p id="p0005" class="elsevierStylePara elsevierViewall">Non-Alcoholic Fatty Liver Disease &#40;NAFLD&#41; constitutes one of the most common forms of liver disease and is considered as the hepatic manifestation of the Metabolic Syndrome &#40;MS&#41;<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> since it is also strongly associated to obesity and insulin resistance&#46;</p><p id="p0010" class="elsevierStylePara elsevierViewall">The severity of NAFLD ranges from hepatic steatosis alone to a triad constituted by&#58; steatosis&#44; hepatocellular necrosis&#44; and inflammation&#59; referred to as non alcoholic steatohepatitis &#40;NASH&#41;&#46;<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="p0015" class="elsevierStylePara elsevierViewall">The true prevalence of NAFLD remains unknown&#46; Among the difficulties in assesing NAFLD prevalence are the absence of signs and symptoms&#44; the sensitivity of liver enzimes to indicate disease and the disputed need for histopatology &#40;liver biopsy&#41; as a gold standard for diagnosis&#46; Depending on which specific diagnosis criteria are used&#44; the prevalence of NAFLD is estimated to range between 10&#37; and 24&#37; in the general population&#46; Variability arises from country to country&#59; in Mexico&#44; one of the largest NAFLD studies<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> reported a frequency of 14&#46;34&#37; in the population between ages 15 and 80 years&#44; compared to a prevalence of 10 to 24&#37; reported in the United States&#46;<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a></p><p id="p0020" class="elsevierStylePara elsevierViewall">In cirrhotic patients<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> liver-related causes of death are classically the main concern in clinical practice&#59; most research is being developed in this field&#46; The most important risk factors for the development of Cardiovascular Disease &#40;CVD&#41; in cirrhotic patients have been analyzed &#40;except for those with primary biliary cirrhosis and nonalcoholic steatohepatitis&#41;&#44; considering CVD is a new but less studied risk that will be increasingly common in this population due to the improved survival that has been observed worldwide&#46; The first interesting finding was that the overall prevalence of MS in patients with liver cirrhosis was similar to that in patients without cirrhosis&#59; although a lower prevalence was observed in male cir-rhotic patients&#46; It is clear that MS is a significant clinical problem in this population&#44; mainly because there are currently no specific guidelines for treatment of MS in patients with liver damage&#44; and controlled clinical trials to prevent complications of MS do not include participants with liver cirrhosis&#46;</p><p id="p0025" class="elsevierStylePara elsevierViewall">Insulin resistance is the underlying condition that facilitates NAFLD&#8217;s occurrence and is the key patho-genetic event of obesity&#44; type 2 Diabetes Mellitus and dyslipidemia&#46; Recently&#44; NAFLD has been included among components of the metabolic syndrome&#59; condition that increases the risk of coronary heart disease and cardiovascular complications&#46; A high prevalence of fatty liver&#44; evaluated by ultrasound&#44; associated with hyperinsulinemia or insulin resistance and cardiovascular disease&#44; has been reported in the general population and in patients with documented coronary artery disease or stroke&#46;</p><p id="p0030" class="elsevierStylePara elsevierViewall">Carotid B mode ultrasound imaging has been used to evaluate carotid atherosclerosis&#46; Intima-media thickness of the carotid artery&#44; a valid parameter for detecting sub-clinical atherosclerosis&#44; has been shown to predict myo-cardial infarction and stroke&#46; Recently&#44; a relationship between NAFLD and atherosclerosis has been reported in healthy man and it has been suggested to reflect the overall adverse impact of the metabolic syndrome&#44; in particular of insulin resistance and increased visceral fat&#46; Endot-helial dysfunction has been reported in NAFLD and re-lated to the metabolic syndrome&#46;</p><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="section0005">The main problem</span><p id="p0035" class="elsevierStylePara elsevierViewall">The current importance of NAFLD and its relationship with the MS has stimulated an interest in the possible role of NAFLD in the development of atherosclerosis&#46; Recent studies have reported the association of NAFLD with multiple classical and non-classical risk factors for CVD&#46; Moreover&#44; there is a strong association between the severity of liver histopathology in NAFLD patients and greater carotid artery intima-media thickness and plaque&#44; and lower endothelial flow-mediated vasodilation &#40;as markers of subclinical atherosclerosis&#41; independently of obesity and other MS components&#46;<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a><span class="elsevierStyleSup">&#44;</span><a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a><a class="elsevierStyleCrossRef" href="#t0005"><span class="elsevierStyleItalic">Table I</span></a> shows studies regarding to CVD and the presence of NAFLD and NASH&#46;</p><elsevierMultimedia ident="t0005"></elsevierMultimedia><p id="p0040" class="elsevierStylePara elsevierViewall">The Free Fatty Acids &#40;FFAs&#41; are increased in obese patients and contribute to the development of type 2 Diabetes Mellitus&#44; hepatic steatosis and several cardiovascular diseases&#46; In patients with heart failure and acute coronary syndromes&#44; elevated FFA levels are a consequence of an increased lipolysis due to a surge in catecholamines and natriuretic peptides&#46; FFAs contribute to myocardial dysfunction and are proarrhythmic&#59; also&#44; their oxidation process requires more oxygen than glycolysis&#46;<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> More recently&#44; several cross-sectional and prospective studies have demonstrated associations of this mechanism with features of the metabolic syndrome and type 2 diabetes mellitus&#46;<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a></p><p id="p0045" class="elsevierStylePara elsevierViewall">Several epidemiological studies indicate that NAFLD&#44; especially in its more severe forms&#44; is linked to an increased risk of CVD&#44; independently of underlying cardi-ometabolic risk factors&#59; Targher et al <a class="elsevierStyleCrossRef" href="#bib0050"><span class="elsevierStyleSup">10</span></a> found that NAFLD is not merely a marker of CVD&#44; but it may be actively involved in its pathogenesis&#46;</p><p id="p0050" class="elsevierStylePara elsevierViewall">In the Diabetes Care work study from Targher&#44;<a class="elsevierStyleCrossRef" href="#bib0055"><span class="elsevierStyleSup">11</span></a> it was found that the prevalence of NAFLD increased with age in patients with type 2 diabetes&#59; &#40;65&#46;4&#37; in aged 40-59 years and 74&#46;6&#37; among those &#62; 60 years&#59; <span class="elsevierStyleItalic">P</span> &#60; 0&#46;001&#41; and the age-adjusted prevalence of NAFLD was 71&#46;1&#37; in men and 68&#37; in women&#46; NAFLD patients had remarkably &#40;P &#60; 0&#46;001&#41; higher age and sex-adjusted prevalences of coronary &#40;26&#46;6&#37; vs 18&#46;3&#37;&#41;&#44; cerebrovascular &#40;20&#46;0&#37; vs 13&#46;3&#37;&#41;&#44; and peripheral &#40;15&#46;4&#37; vs 10&#46;0&#37;&#41; vascular disease than their counterparts without NAFLD <a class="elsevierStyleCrossRef" href="#f0005"><span class="elsevierStyleItalic">&#40;Figure 1&#41;&#46;</span></a></p><elsevierMultimedia ident="f0005"></elsevierMultimedia><p id="p0055" class="elsevierStylePara elsevierViewall">Abdeen <span class="elsevierStyleItalic">et al</span> state that in the cardiometabolic syndrome &#40;a constellation of metabolic&#44; cardiovascular&#44; renal&#44; and inflammatory abnormalities in which insulin resistance is thought to play a key role in end-organ patho-genesis&#41;&#44;<a class="elsevierStyleCrossRef" href="#bib0060"><span class="elsevierStyleSup">12</span></a> the release of pro-atherogenic factors from the liver &#40;C-reactive protein&#44; fibrinogen&#44; plasminogen activator inhibitor-1 and other inflammatory cytokines&#41; as well as the contribution of NAFLD per se to whole-body insulin resistance and atherogenic dyslipidemia&#44; favour CVD progression&#46;</p><p id="p0060" class="elsevierStylePara elsevierViewall">Plasma concentrations of high-sensitivity C-reactive protein &#40;hs-CRP&#41;&#44; fibrinogen&#44; plasminogen activator in-hibitor-1 &#40;PAI-1&#41; activity&#44; and adiponectin were reviewed by Targher <span class="elsevierStyleItalic">et al</span> in 45 overweight male patients with biopsy-proven NASH&#44; 45 overweight male patients without ultrasound-diagnosed hepatic steatosis&#44; and 45 healthy male volunteers&#59;<a class="elsevierStyleCrossRef" href="#bib0065"><span class="elsevierStyleSup">13</span></a> the lowest values were in nonobese healthy subjects&#44; intermediate in overweight nonsteatotic patients&#44; and the highest in those with biopsy-proven NASH&#59; on the other hand&#44; the highest and lowest adi-ponectin levels were found in nonobese healty subjects and in biopsy-proven NASH patients&#44; respectively&#46; In their review&#44; they concluded that the presence of NASH can predict a more atherogenic risk profile in a manner that is partly independent from the contribution of visceral adiposity in adult men&#46;</p><p id="p0065" class="elsevierStylePara elsevierViewall">A large trial performed in Asia with 30&#44;172 subjects studied the severity of NAFLD&#44; characterized a nonobese population and analyzed the prevalence of CVD risk factors and used the Framingham risk score for CVD&#59; the odds ratio for 10-year risk by total Framingham risk scores &#62; 10&#37; was 5&#46;3 times higher in NASH groups&#46; CVD risk was significantly greater in patients with NASH than in patients with either steatosis or raised ALT alone&#46;<a class="elsevierStyleCrossRef" href="#bib0070"><span class="elsevierStyleSup">14</span></a></p><p id="p0070" class="elsevierStylePara elsevierViewall">Lizardi-Cervera et al<a class="elsevierStyleCrossRef" href="#bib0075"><span class="elsevierStyleSup">15</span></a> demonstrated that subjects with NAFLD had several forms of metabolic disturbances and a high prevalence of MS&#46; They found higher levels of uCRP &#40;ultrasensitivity C-reactive protein&#41; in subjects with NAFLD and observed in this subjects had more metabolic abnormalities and a higher prevalence of MS&#59; which explained the higher concentrations of uCRP&#46; They compared 310 subjects with ultrasound-demonstrated steatosis to 610 control cases&#46; They found statistically significant differences between both groups&#59; the frequency of MS was 66&#46;4&#37; in the study population compared to 26&#46;7&#37; found in the control group <span class="elsevierStyleItalic">&#40;P &#60;</span> 0&#46;001&#41;&#46; Patients in the steatosis group were older&#44; had higher BMIs&#44; glucose&#44; total cholesterol and triglycerides &#40;P &#60; 0&#46;001&#41;&#44; as well as mean uCRP concentrations &#40;4&#46;5 vs 2&#46;79 mg&#47;L&#59; <span class="elsevierStyleItalic">P &#60;</span> 0&#46;001&#41; <a class="elsevierStyleCrossRef" href="#t0010"><span class="elsevierStyleItalic">&#40;Table II&#41;&#46;</span></a> Cardiovascular risk was also higher in subjects with NAFLD &#40;4&#46;7 vs 2&#46;8&#41; <a class="elsevierStyleCrossRef" href="#f0010"><span class="elsevierStyleItalic">&#40;Figure 2&#41;&#46;</span></a></p><elsevierMultimedia ident="t0010"></elsevierMultimedia><elsevierMultimedia ident="f0010"></elsevierMultimedia><p id="p0075" class="elsevierStylePara elsevierViewall">With regard to carotid atherosclerosis&#44; a significant difference in mean values of intima-media thickness &#40;0&#46;89 &#43; 0&#46;26 <span class="elsevierStyleItalic">vs</span> 0&#46;64 &#43; 0&#46;14 mm&#44; P &#61; &#46;0001&#41; and prevalence of plaques &#40;26 &#91;21&#37;&#93; vs 15 &#91;6&#37;&#93;&#44; P &#60; &#46;001&#41; was observed between nonalcoholic fatty liver disease patients and controls in a study performed by Francanzani <span class="elsevierStyleItalic">et al</span><a class="elsevierStyleCrossRef" href="#bib0080"><span class="elsevierStyleSup">16</span></a> in 375 patients &#40;125 patients with NAFLD and 250 controls&#41;&#46;</p><p id="p0080" class="elsevierStylePara elsevierViewall">Steatosis was the strongest variable independently associated to intima-media thickness and to an increased risk of atherosclerosis in subjects with metabolic syndrome&#46; It is important to mention that the strongest independent risk predictor of vascular damage was steatosis followed by age and systolic blood pressure&#46;</p><p id="p0085" class="elsevierStylePara elsevierViewall">It was recently shown that patients with NAFLD have endothelial dysfunction potentially responsible for cardiovascular disease in the long term<a class="elsevierStyleCrossRef" href="#bib0085"><span class="elsevierStyleSup">17</span></a>&#46; Enhaced oxidative stress&#44; inflammation with release of inflammatory cytokines&#44; and abnormal lipoprotein metabolism could account for the proatherogenic effect of NAFLD&#59; in addition to this&#44; increased levels of ox-LDL in patients with higher intima media thickness&#46; Visceral fat&#44; even in normal weight or slightly overweight subjects with steatosis&#44; could play a direct role in the development of atherosclerosis through multiple secreted factors&#46;<a class="elsevierStyleCrossRef" href="#bib0090"><span class="elsevierStyleSup">18</span></a></p><p id="p0090" class="elsevierStylePara elsevierViewall">Also&#44; a Turkish study by Cikim<a class="elsevierStyleCrossRef" href="#bib0095"><span class="elsevierStyleSup">19</span></a> evaluated the relationship between hepatic steatosis&#44; epicardial adipose tissue &#40;EAT&#41; and insulin resistance in obese patients&#46; They found EAT was high in all groups&#44; suggesting that hepatic steatosis should be assessed as a predictor that reflects the increments of whole body fat mass as well as abdominal adiposity&#46;</p><p id="p0095" class="elsevierStylePara elsevierViewall">The Study of Chavez-Tapia <span class="elsevierStyleItalic">et al</span> in Mexico City an-alized 1&#44;421 subjects with NAFLD and MS&#46; Among these patients a systolic blood pressure &#62; 130 mmHg was associated with a positive treadmill test with an OR &#61; 4&#46;705 &#40;95&#37; CI 1&#46;285-17&#46;231&#41;&#46; Interestingly&#44; waist circumference an MS remained as risk factors related to positive treadmill tests &#40;OR &#61; 8&#46;750&#44; 95&#37;CI 1&#46;83041&#46;843&#59; and OR &#61; 3&#46;802&#44; 95&#37; CI 1&#46;121-12&#46;987&#44; respec-tivetely&#41;&#46; They concluded that subjects with NAFLD and high systolic blood preassure are at increased risk to develop CVD&#46;<a class="elsevierStyleCrossRef" href="#bib0100"><span class="elsevierStyleSup">20</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="section0010">Conclusions</span><p id="p0100" class="elsevierStylePara elsevierViewall">Today&#8217;s lifestyle represents a huge challenge for health-care providers&#46; Most meals are full of carbs&#44; lipids and have high caloric contents&#59; thus helping to increase the prevalence of MS and its consequences such as NAFLD and increased CVD-related mortality&#46;</p><p id="p0105" class="elsevierStylePara elsevierViewall">As mentioned above&#44; NAFLD is associated to an increased risk to develop cardiovascular disease which augments as the hepatic damage progresses&#46; The presence of NAFLD would predict a higher atherogenic risk regardless of the other components of the MS&#46; It is proba-ble that NAFLD may not be a marker of CVD&#44; but it may certainly be involved in its pathogenesis&#59; more studies are needed to prove this hypothesis&#46; Patients with NAFLD regardless of their liver function tests should be considered at a higher risk to develop complications from CVD&#46;</p><p id="p0110" class="elsevierStylePara elsevierViewall">What we see today is yet the top of the iceberg of what could be one of the main diseases for the years to come since the incidence of both MS and NAFLD will increase&#46; It is of serious importance to take an aggressive preventive measures in this group of patients&#46;</p></span></span>"
    "textoCompletoSecciones" => array:1 [
      "secciones" => array:5 [
        0 => array:3 [
          "identificador" => "xres1212005"
          "titulo" => "Abstract"
          "secciones" => array:1 [
            0 => array:1 [
              "identificador" => "abst0005"
            ]
          ]
        ]
        1 => array:2 [
          "identificador" => "xpalclavsec1128075"
          "titulo" => "Key words"
        ]
        2 => array:2 [
          "identificador" => "sec0005"
          "titulo" => "The main problem"
        ]
        3 => array:2 [
          "identificador" => "sec0010"
          "titulo" => "Conclusions"
        ]
        4 => array:1 [
          "titulo" => "References"
        ]
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "fechaRecibido" => "2008-10-17"
    "fechaAceptado" => "2008-10-17"
    "PalabrasClave" => array:1 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Key words"
          "identificador" => "xpalclavsec1128075"
          "palabras" => array:2 [
            0 => "NAFLD"
            1 => "NASH and cardiovascular disease"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:1 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<span id="abst0005" class="elsevierStyleSection elsevierViewall"><p id="sp0025" class="elsevierStyleSimplePara elsevierViewall">An association between non-alcoholic fatty liver disease &#40;NAFLD&#41; and cardiovascular disease &#40;CVD&#41; has been recently suggested&#46; Indeed&#44; different studies have demonstrated that NAFLD patients present increased subclinical atherosclerosis compared to non-steatosic individuals&#44; and are supported by the few follow-up studies revealing that CVD is the second most common cause of death in NAFLD patients&#46; However&#44; the nature of the relationship NAFLD&#47;CVD is still under debate&#46;</p></span>"
      ]
    ]
    "multimedia" => array:4 [
      0 => array:7 [
        "identificador" => "f0005"
        "etiqueta" => "Figure 1"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr1.jpeg"
            "Alto" => 680
            "Ancho" => 977
            "Tamanyo" => 41026
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="sp0005" class="elsevierStyleSimplePara elsevierViewall">The prevalence of CVD in patients with NAFLD associated to type 2 diabetes mellitus&#46;</p>"
        ]
      ]
      1 => array:7 [
        "identificador" => "f0010"
        "etiqueta" => "Figure 2"
        "tipo" => "MULTIMEDIAFIGURA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "figura" => array:1 [
          0 => array:4 [
            "imagen" => "gr2.jpeg"
            "Alto" => 906
            "Ancho" => 980
            "Tamanyo" => 41063
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="sp0010" class="elsevierStyleSimplePara elsevierViewall">Relative risk for cardiovascular disease between cases and patients with NAFLD&#46;</p>"
        ]
      ]
      2 => array:7 [
        "identificador" => "t0005"
        "etiqueta" => "Table I"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Author&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Year&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Population&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle"><span class="elsevierStyleItalic">N</span>&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Findings&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Sankatsing&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2005&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Dyslipidemia&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">32&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Familiar dyslipidema is a risk factor for NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Santoliquido&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2005&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">1209&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2&#44;1 Relative risk to develop stroke in patients with NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Abden&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2006&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD and NASH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Review&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD and NASK is a risk factor for CVD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Browning&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2006&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD and NASH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2264&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Statin use is not associated to an increased NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Targher&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2006&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD and NASH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">85&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD is associated to increased incidence of carotid atherosclerosis and hepatic damage&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Schindhelm&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2007&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Review&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Association of ALT level with the development of CVD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Targher&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2007&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Review&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">The association between severity of hepatic damage and the intima-media thickness of the carotid artery&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Cikim&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2007&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">63&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD and its association to increased epidardic adipose tissue&#44; insulin resistance and high levels of C-Reactive protein&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Lizardi-Cervera&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2007&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">310&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">higher levels of uCRP &#40;ultrasensitivity C-reactive protein&#41; in subjects with NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Akabame&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">298&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2&#46;6 Relative Risk of having coronary atherosclerosis in patients with NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Francanzani&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">375&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD and its association of the intima thinnering of the carotid artery and hypertension&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Sung KC&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD and NASH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">30&#44; 172&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">5&#46;3 Relative Risk of CVD in NASH than in other NAFLD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Targher&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD and TYPE 2 DM&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">52&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NAFLD as a independent risk factor of CVD and atherosclerosis&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Targher&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NASH&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">45&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">High levels of C-Reactive protein&#44; fibrinogen&#44; plasminogen and cytokines&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Targher&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">NASH and obesity&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">45&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Non-obese patients with NASH have increased risk to develop CVD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Pilz&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2008&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Obesity&#44; NAFLD and CVD&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Review&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">Increased incidence of Free Fatty Acids in blood serum&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2069123.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="sp0015" class="elsevierStyleSimplePara elsevierViewall">Studies regarding to CVD and the presence of NAFLD and NASH&#46;</p>"
        ]
      ]
      3 => array:7 [
        "identificador" => "t0010"
        "etiqueta" => "<span class="elsevierStyleBold">Table II&#46;</span>"
        "tipo" => "MULTIMEDIATABLA"
        "mostrarFloat" => true
        "mostrarDisplay" => false
        "tabla" => array:1 [
          "tablatextoimagen" => array:1 [
            0 => array:2 [
              "tabla" => array:1 [
                0 => """
                  <table border="0" frame="\n
                  \t\t\t\t\tvoid\n
                  \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="left" valign="middle" scope="col">Variable&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="middle" scope="col">OR &#40;CI95&#37;&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th><th class="td" title="\n
                  \t\t\t\t\ttable-head\n
                  \t\t\t\t  " align="center" valign="middle" scope="col">p value&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Age&#58; &#62;45 vs &#60;45 years&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">1&#46;90 &#40;1&#46;44-2&#46;51&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&#60; 0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Gender&#58; male vs female&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">1&#46;78 &#40;1&#46;40-2&#46;26&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&#60; 0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">BMI&#58; &#62; 27 vs &#60; 27&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">5&#46;54 &#40;4&#46;09-7&#46;49&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&#60; 0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Glucose&#58; &#62; 5&#46;55 vs &#60; 5&#46;55&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">mmol&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">4&#46;09 &#40;2&#46;98-5&#46;61&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&#60; 0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Total cholesterol&#58; &#62; 2&#46;59 vs &#62;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">2&#46;59 mmol&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">1&#46;71 &#40;1&#46;29-2&#46;27&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&#60; 0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">HDL cholesterol&#58; &#60; 1&#46;16 vs &#62;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">1&#46;16 mmol&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">2&#46;15 &#40;1&#46;58-2&#46;91&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&#60; 0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">Triglycerides&#58; &#62; 2&#46;26 vs &#60;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">2&#46;26 mmol&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">3&#46;34 &#40;2&#46;50-4&#46;46&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&#60; 0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">CPR &#62; 3 vs &#60; 1 mg&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">7&#46;06 &#40;4&#46;51-11&#46;02&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&#60; 0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="left" valign="middle">CPR &#62; 3 <span class="elsevierStyleItalic">vs</span> &#60; 1 mg&#47;L&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">5&#46;83 &#40;3&#46;07-11&#46;06&#41;&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td><td class="td" title="\n
                  \t\t\t\t\ttable-entry\n
                  \t\t\t\t  " align="center" valign="middle">&#60; 0&#46;001&nbsp;\t\t\t\t\t\t\n
                  \t\t\t\t</td></tr></tbody></table>
                  """
              ]
              "imagenFichero" => array:1 [
                0 => "xTab2069122.png"
              ]
            ]
          ]
        ]
        "descripcion" => array:1 [
          "en" => "<p id="sp0020" class="elsevierStyleSimplePara elsevierViewall">Univariated and multivariated analysis of anthropometric and metabolic variables and C reactive protein values according to cardiovascular risk&#46;</p>"
        ]
      ]
    ]
    "bibliografia" => array:2 [
      "titulo" => "References"
      "seccion" => array:1 [
        0 => array:2 [
          "identificador" => "bibs0005"
          "bibliografiaReferencia" => array:20 [
            0 => array:3 [
              "identificador" => "bib0005"
              "etiqueta" => "1&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Obesidad y esteatohepatitis no alcoh&#243;lica"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "N M&#233;ndez-S&#225;nchez"
                            1 => "N Ch&#225;vez-Tapia"
                            2 => "M&#46; Unbe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Gac Med M&#233;x"
                        "fecha" => "2004"
                        "numero" => "140"
                        "paginaInicial" => "S67"
                        "paginaFinal" => "S72"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            1 => array:3 [
              "identificador" => "bib0010"
              "etiqueta" => "2&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Relaci&#243;n entre el sobrepeso y obesidad con mortalidad por cirrosis hep&#225;tica en M&#233;xico"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "N M&#233;ndez-S&#225;nchez"
                            1 => "C&#46;P&#46; S&#225;nchez-Castillo"
                            2 => "A&#46;R&#46; Villar"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:5 [
                        "tituloSerie" => "Rev Gastroenterol Mex"
                        "fecha" => "2003"
                        "volumen" => "68"
                        "numero" => "Supl 3"
                        "paginaInicial" => "176"
                      ]
                    ]
                  ]
                ]
              ]
            ]
            2 => array:3 [
              "identificador" => "bib0015"
              "etiqueta" => "3&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "H&#237;gado graso no alcoh&#243;lico y s&#237;ndrome metab&#243;lico"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J Lizardi-Cervera"
                            1 => "I Becerra-Laparra"
                            2 => "N Ch&#225;vez-Tapia"
                            3 => "Me&#46; RamosOstos"
                            4 => "M&#46; Uribe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "Rev Gastroenterol Mex"
                        "fecha" => "2006"
                        "volumen" => "71"
                        "numero" => "4"
                        "paginaInicial" => "453"
                        "paginaFinal" => "459"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17542278"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            3 => array:3 [
              "identificador" => "bib0020"
              "etiqueta" => "4&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonalcoholic fatty liver disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "P&#46; Angulo"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1056/NEJMra011775"
                      "Revista" => array:7 [
                        "tituloSerie" => "N Engl J Med"
                        "fecha" => "2002"
                        "volumen" => "346"
                        "numero" => "16"
                        "paginaInicial" => "1221"
                        "paginaFinal" => "1231"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/11961152"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            4 => array:3 [
              "identificador" => "bib0025"
              "etiqueta" => "5&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Metabolic syndrome and estimates of cardiovascular disease in cirrhotic patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:7 [
                            0 => "N Ch&#225;vez-Tapia"
                            1 => "F T&#233;llez-&#193;vila"
                            2 => "M Vald&#233;s-Esc&#225;rcega"
                            3 => "M Monta&#241;o-Reyes"
                            4 => "M&#46;H&#46; Ramos"
                            5 => "J Lizardi-Cervera"
                            6 => "M&#46; Uribe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:6 [
                        "tituloSerie" => "J Dig Dis"
                        "fecha" => "2008"
                        "volumen" => "9"
                        "paginaInicial" => "149"
                        "paginaFinal" => "155"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18956593"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            5 => array:3 [
              "identificador" => "bib0030"
              "etiqueta" => "6&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Increased risk of cardiovascular disease in non-alcoholic fatty liver disease&#58; causal effect or epiphenomenon&#63;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "G Targher"
                            1 => "F Marra"
                            2 => "G&#46; Marchesini"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s00125-008-1135-4"
                      "Revista" => array:8 [
                        "tituloSerie" => "Diabetologia"
                        "fecha" => "2008"
                        "volumen" => "51"
                        "numero" => "11"
                        "paginaInicial" => "1947"
                        "paginaFinal" => "1953"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18762907"
                            "web" => "Medline"
                          ]
                        ]
                        "itemHostRev" => array:3 [
                          "pii" => "S0161642017324533"
                          "estado" => "S300"
                          "issn" => "01616420"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            6 => array:3 [
              "identificador" => "bib0035"
              "etiqueta" => "7&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Obesity&#44; inflammation&#44; and insulin resistance"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "S&#46;E&#46; Shoelson"
                            1 => "L Herrero"
                            2 => "A&#46; Naaz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1053/j.gastro.2007.03.059"
                      "Revista" => array:6 [
                        "tituloSerie" => "Gastroenterology"
                        "fecha" => "2007"
                        "volumen" => "132"
                        "paginaInicial" => "2169"
                        "paginaFinal" => "2180&#46;"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17498510"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            7 => array:3 [
              "identificador" => "bib0040"
              "etiqueta" => "8&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Free fatty acids as a cardiovascular risk factor"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:2 [
                            0 => "S Pilz"
                            1 => "W&#46; M&#228;rz"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1515/CCLM.2008.118"
                      "Revista" => array:7 [
                        "tituloSerie" => "Clin Chem Lab Med"
                        "fecha" => "2008"
                        "volumen" => "46"
                        "numero" => "4"
                        "paginaInicial" => "429"
                        "paginaFinal" => "434"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18605928"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            8 => array:3 [
              "identificador" => "bib0045"
              "etiqueta" => "9&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Obesity increases sensitivity to exotoxin liver injury&#58; Implications for the pathogenesis of steatohepatitis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "S&#46;Q&#46; Yang"
                            1 => "H&#46;Z&#46; Lin"
                            2 => "M&#46;D&#46; Lande"
                            3 => "M Clemens"
                            4 => "AM&#46; Diehl"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1073/pnas.94.6.2557"
                      "Revista" => array:7 [
                        "tituloSerie" => "Proc Natl Acad Sci USA"
                        "fecha" => "1997"
                        "volumen" => "94"
                        "numero" => "6"
                        "paginaInicial" => "2557"
                        "paginaFinal" => "2562"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/9122234"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            9 => array:3 [
              "identificador" => "bib0050"
              "etiqueta" => "10&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Non-alcoholic fatty liver disease&#44; the metabolic syndrome and the risk of cardiovascular disease&#58; the plot thickens"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:1 [
                            0 => "G&#46; Targher"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1464-5491.2007.02125.x"
                      "Revista" => array:7 [
                        "tituloSerie" => "Diabet Med"
                        "fecha" => "2007"
                        "volumen" => "24"
                        "numero" => "1"
                        "paginaInicial" => "1"
                        "paginaFinal" => "6"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17313594"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            10 => array:3 [
              "identificador" => "bib0055"
              "etiqueta" => "11&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:8 [
                            0 => "G Targher"
                            1 => "L Bertolini"
                            2 => "R Padovani"
                            3 => "S Rodella"
                            4 => "R Tessari"
                            5 => "L Zenari"
                            6 => "C Day"
                            7 => "G&#46; Arcaro"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.2337/dc06-2247"
                      "Revista" => array:7 [
                        "tituloSerie" => "Diabetes Care"
                        "fecha" => "2007"
                        "volumen" => "30"
                        "numero" => "5"
                        "paginaInicial" => "1212"
                        "paginaFinal" => "1218"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17277038"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            11 => array:3 [
              "identificador" => "bib0060"
              "etiqueta" => "12&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Nonalcoholic steatohepatitis and the cardiometabolic syndrome"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:4 [
                            0 => "M&#46;B&#46; Abdeen"
                            1 => "N&#46;A&#46; Chowdhury"
                            2 => "M&#46;R&#46; Hayden"
                            3 => "JA&#46; Ibdah"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:7 [
                        "tituloSerie" => "J Cardiometab Syndr"
                        "fecha" => "2006"
                        "volumen" => "1"
                        "numero" => "1"
                        "paginaInicial" => "36"
                        "paginaFinal" => "40"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17675901"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            12 => array:3 [
              "identificador" => "bib0065"
              "etiqueta" => "13&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "NASH predicts plasma inflammatory biomarkers independently of visceral fat in men"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:8 [
                            0 => "G Targher"
                            1 => "L Bertolini"
                            2 => "S Rodella"
                            3 => "G Lippi"
                            4 => "M Franchini"
                            5 => "G Zoppini"
                            6 => "M Muggeo"
                            7 => "CP&#46; Day"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1038/oby.2008.64"
                      "Revista" => array:7 [
                        "tituloSerie" => "Obesity"
                        "fecha" => "2008"
                        "volumen" => "16"
                        "numero" => "6"
                        "paginaInicial" => "1394"
                        "paginaFinal" => "1399"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18369343"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            13 => array:3 [
              "identificador" => "bib0070"
              "etiqueta" => "14&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "K&#46;C&#46; Sung"
                            1 => "M&#46;C&#46; Ryan"
                            2 => "A&#46;M&#46; Wilson"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:3 [
                        "tituloSerie" => "Atherosclerosis"
                        "fecha" => "2008"
                        "itemHostRev" => array:3 [
                          "pii" => "S0161642017324533"
                          "estado" => "S300"
                          "issn" => "01616420"
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            14 => array:3 [
              "identificador" => "bib0075"
              "etiqueta" => "15&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Association among C-reactive protein&#44; Fatty liver disease&#44; and cardiovascular risk"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:5 [
                            0 => "J Lizardi-Cervera"
                            1 => "N&#46;C&#46; Ch&#225;vez-Tapia"
                            2 => "O P&#233;rez-Bautista"
                            3 => "M&#46;H&#46; Ramos"
                            4 => "M&#46; Uribe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/s10620-006-9262-6"
                      "Revista" => array:7 [
                        "tituloSerie" => "Dig Dis Sci"
                        "fecha" => "2007"
                        "volumen" => "52"
                        "numero" => "9"
                        "paginaInicial" => "2375"
                        "paginaFinal" => "2379"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17458697"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            15 => array:3 [
              "identificador" => "bib0080"
              "etiqueta" => "16&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Carotid artery intima-media thickness in nonalcoholic fatty liver disease&#46;"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:10 [
                            0 => "A&#46;L&#46; Fracanzani"
                            1 => "L Burdick"
                            2 => "S Raselli"
                            3 => "P Pedotti"
                            4 => "L Grigore"
                            5 => "G Santorelli"
                            6 => "L Valenti"
                            7 => "A Maraschi"
                            8 => "A Catapano"
                            9 => "S&#46; Fargion"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1016/j.amjmed.2007.08.041"
                      "Revista" => array:7 [
                        "tituloSerie" => "Am J Med"
                        "fecha" => "2008"
                        "volumen" => "121"
                        "numero" => "1"
                        "paginaInicial" => "72"
                        "paginaFinal" => "78"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/18187076"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            16 => array:3 [
              "identificador" => "bib0085"
              "etiqueta" => "17&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "N Villanova"
                            1 => "S Moscatiello"
                            2 => "S&#46; Ramillis"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1002/hep.20781"
                      "Revista" => array:6 [
                        "tituloSerie" => "Hepatology"
                        "fecha" => "2005"
                        "volumen" => "42"
                        "paginaInicial" => "473"
                        "paginaFinal" => "480&#46;"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15981216"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            17 => array:3 [
              "identificador" => "bib0090"
              "etiqueta" => "18&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Systemic levels of lipid peroxidation and its metabolic and dietary correlates in patients with nonalcoholic steatohepatitis"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:3 [
                            0 => "N Chalasani"
                            1 => "M&#46;A&#46; Deeg"
                            2 => "DW&#46; Crab"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1111/j.1572-0241.2004.30159.x"
                      "Revista" => array:6 [
                        "tituloSerie" => "Am J Gastroenterol"
                        "fecha" => "2004"
                        "volumen" => "99"
                        "paginaInicial" => "1497"
                        "paginaFinal" => "1502"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/15307867"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            18 => array:3 [
              "identificador" => "bib0095"
              "etiqueta" => "19&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Epicardial adipose tissue&#44; hepatic steatosis and obesity"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:9 [
                            0 => "A&#46;S&#46; Cikim"
                            1 => "E Topal"
                            2 => "M Harputluoglu"
                            3 => "L Keskin"
                            4 => "Z Zengin"
                            5 => "K Cikim"
                            6 => "R Ozdemir"
                            7 => "M Aladag"
                            8 => "S&#46; Yologlu"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:2 [
                      "doi" => "10.1007/BF03346328"
                      "Revista" => array:7 [
                        "tituloSerie" => "J Endocrinol Invest"
                        "fecha" => "2007"
                        "volumen" => "30"
                        "numero" => "6"
                        "paginaInicial" => "459"
                        "paginaFinal" => "464"
                        "link" => array:1 [
                          0 => array:2 [
                            "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17646719"
                            "web" => "Medline"
                          ]
                        ]
                      ]
                    ]
                  ]
                ]
              ]
            ]
            19 => array:3 [
              "identificador" => "bib0100"
              "etiqueta" => "20&#46;"
              "referencia" => array:1 [
                0 => array:2 [
                  "contribucion" => array:1 [
                    0 => array:2 [
                      "titulo" => "Differential risk factor patterns for a positive treadmill test among subjects with and without ultrasound-based fatty liver"
                      "autores" => array:1 [
                        0 => array:2 [
                          "etal" => false
                          "autores" => array:9 [
                            0 => "N Chavez-Tapia"
                            1 => "F&#46;I&#46; Tellez-Avila"
                            2 => "M Valdes-Escarcega"
                            3 => "O Perez-Bautista"
                            4 => "J Lizardi-Cervera"
                            5 => "N M&#233;ndez-S&#225;nchez"
                            6 => "J&#46;F&#46; S&#225;nchez-Avila"
                            7 => "M&#46;H&#46; Ramos"
                            8 => "M&#46; Uribe"
                          ]
                        ]
                      ]
                    ]
                  ]
                  "host" => array:1 [
                    0 => array:1 [
                      "Revista" => array:2 [
                        "tituloSerie" => "Arch Med Sci"
                        "fecha" => "2009"
                      ]
                    ]
                  ]
                ]
              ]
            ]
          ]
        ]
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/16652681/00000008000000S1/v1_201906260858/S1665268119318253/v1_201906260858/en/main.assets"
  "Apartado" => null
  "PDF" => "https://static.elsevier.es/multimedia/16652681/00000008000000S1/v1_201906260858/S1665268119318253/v1_201906260858/en/main.pdf?idApp=UINPBA00004N&text.app=https://www.elsevier.es/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1665268119318253?idApp=UINPBA00004N"
]

Article information

ISSN: 16652681
Original language: English

DOI:10.1016/S1665-2681(19)31825-3

The statistics are updated each day

Year/Month	Html	Pdf	Total

2024 November	2	0	2
2024 October	35	9	44
2024 September	46	6	52
2024 August	52	7	59
2024 July	56	12	68
2024 June	42	11	53
2024 May	47	5	52
2024 April	71	6	77
2024 March	117	7	124
2024 February	86	13	99
2024 January	84	16	100
2023 December	50	11	61
2023 November	52	20	72
2023 October	27	12	39
2023 September	22	5	27
2023 August	22	6	28
2023 July	20	6	26
2023 June	42	6	48
2023 May	61	9	70
2023 April	60	4	64
2023 March	47	9	56
2023 February	29	9	38
2023 January	25	8	33
2022 December	27	6	33
2022 November	23	16	39
2022 October	19	7	26
2022 September	13	6	19
2022 August	16	12	28
2022 July	21	8	29
2022 June	22	4	26
2022 May	29	12	41
2022 April	17	9	26
2022 March	13	7	20
2022 February	25	4	29
2022 January	37	6	43
2021 December	11	9	20
2021 November	14	9	23
2021 October	18	11	29
2021 September	38	9	47
2021 August	13	7	20
2021 July	13	9	22
2021 June	10	9	19
2021 May	21	8	29
2021 April	30	25	55
2021 March	14	30	44
2021 February	5	7	12
2021 January	6	10	16
2020 December	6	2	8
2020 November	4	4	8
2020 October	7	4	11
2020 September	4	4	8
2020 August	8	6	14
2020 July	9	7	16
2020 June	7	3	10
2020 May	6	8	14
2020 April	4	3	7
2020 March	7	5	12
2020 February	5	3	8
2020 January	9	6	15
2019 December	5	8	13
2019 November	7	0	7
2019 October	1	2	3
2019 September	1	0	1
2019 August	1	2	3
2019 July	2	9	11
2019 June	2	6	8

Show all

Indexed in:

Follow us:

Statistics

Indexed in:

Follow us:

Statistics

Subscribe to our newsletter